ClinicaSpace.com
Clinical Research
News & Careers		  
Search the Site
    
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login


NEWSLETTERS
FREE Newsletters
Archive
My Subscriptions
 

 
NEWS
News by Subject
News by Date
Search News
Post Your News
JoVE
 

 
CAREER NETWORK
Job Seeker Login
Today's Hot Jobs
Most Recent Jobs
Search Jobs
Post Resume
Career Resources
For Employers
  

 
PROFILES
Company Profiles
 

 
INDUSTRY EVENTS
Clinical
 

 
RESOURCES
Real Estate
New Business Opportunities

 News | News By Subject | News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Print   Email 

Cubist Pharmaceuticals, Inc. (CBST) Receives CUBICIN Paragraph IV Notice Letter


2/9/2012 6:37:17 AM

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it has received a Paragraph IV Notice Letter from Hospira, Inc. advising of the filing of an Abbreviated New Drug Application (ANDA) for a generic version of CUBICIN® (daptomycin for injection).

Read at BioSpace.com
 
 Read Article at  Related Companies  News Categories
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 
    
About ClinicaSpace | Contact Us | Privacy Statement | Terms of Use
Post Your News | Post Event | Post Jobs | Post Company Profile | Advertising Opportunities

RSS FEED All News - Medical Device | Breaking News - Medical Device | Featured Stories - Medical Device

© ClinicaSpace - an onTargetjobs company
Visit other onTargetjobs companies
Niche Job Boards | Biotechnology Jobs | Healthcare Jobs | Nursing Jobs | Accounting Jobs | Hospitality Jobs
Hospitality Jobs Canada | Hospitality Jobs UK